Histamine H3 inverse agonists and antagonists and methods of use thereof

Details for Australian Patent Application No. 2010214101 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Chytil, Milan; Engel, Sharon R.; Fang, Qun Kevin; Spear, Kerry L.

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010214101

PCT Pub. Number WO2010/093425

Priority 61/151,817 11.02.09 US

Filing date 11 February 2010

Wipo publication date 19 August 2010

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/093425 Priority application(s): WO2010/093425

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214102-Locate apparatus having enhanced features for underground facility locate operations, and associated methods and systems

2010214100-Methods, apparatus, and systems for facilitating and/or verifying locate and/or marking operations